Patents by Inventor Ling Chai

Ling Chai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260255006
    Abstract: The proposed live streaming recommendation method includes: determining a plurality of traffic feature sequences of a live stream that correspond to a plurality of interaction operations, where the plurality of interaction operations is initiated by viewing users in the live stream, and in each of the plurality of traffic feature sequences, different traffic features represent feature information corresponding to an interaction operation in different historical time slices of the live stream; determining, at least based on the plurality of traffic feature sequences, predicted traffic changes of the live stream respectively corresponding to the plurality of interaction operations in a target time slice; and determining a recommendation degree of the live stream for a user group at least based on a recommendation request of the user group and the predicted traffic changes of the live stream respectively corresponding to the plurality of interaction operations in the target time slice.
    Type: Application
    Filed: February 9, 2026
    Publication date: August 27, 2026
    Inventors: Rui LI, Pengyuan GAO, Haihan LI, Ling CHAI, Shaohao HUANG, Ting XIE
  • Patent number: 6214795
    Abstract: This invention provides peptide compounds that bind to either a fibroblast growth factor (FGF) or a fibroblast growth factor receptor (FGFR) and, accordingly, are useful for modulating FGFR activity. Preferably, the FGFR is FGFR2-IIIC. Preferably, the FGF is basic FGF. Preferably the peptide compound comprises an amino acid sequence: (Y/F)-(L/F/I)-(R/D/E/S/Y/G)-(Q/L/Y)-Y-(M/L/K/R)-(L/M/D/E/N/S)-(R/L/S/T)-(L/F/M/V) (SEQ ID NO: 1). The invention further comprises pharmaceutical compositions comprising the peptide compounds of the invention and a pharmaceutically acceptable carrier. The invention still further provides methods of modulating FGFR activity using the peptide compounds of the invention.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: April 10, 2001
    Assignee: Praecis Pharmaceuticals, Inc.
    Inventors: Howard Benjamin, Ling Chai, Mark A. Findeis, William Goodwin, Arvind Hundal, David I. Israel, Michael Kelley, Martin P. Keough, Kuanghui Lu, Farah Natoli, Alicia Peticolas, Ethan R. Signer, Malcolm L. Gefter